ERFA-AMIKACIN

searchlight pharma inc🇨🇦 Health Canada

Approval Id: b6a0ff547c6ef551
Drug Approval Canada Name: ERFA-AMIKACIN
Product Name: ERFA-AMIKACIN
Status: Cancelled Post Market
Status Date: 2024-11-22
Original Market Date: 2019-11-29
Din: 02489147
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous , Intramuscular
Schedule: Prescription
Ahfs: 08:12.02
Atc Original: J01GB06 AMIKACIN
Atc Name: j 01 gb 06
Aig Number: 0111922001
Company Name: searchlight pharma inc
Company Address: 1600 Rue Notre Dame Ouest, Suite 312, Montreal, Quebec, Canada, H3J 1M1

AMIKACIN (AMIKACIN SULFATE)

250 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b6a0ff547c6ef551

Type

Standard